BG63804B1 - Метод за получаване на епросартан - Google Patents

Метод за получаване на епросартан Download PDF

Info

Publication number
BG63804B1
BG63804B1 BG103650A BG10365099A BG63804B1 BG 63804 B1 BG63804 B1 BG 63804B1 BG 103650 A BG103650 A BG 103650A BG 10365099 A BG10365099 A BG 10365099A BG 63804 B1 BG63804 B1 BG 63804B1
Authority
BG
Bulgaria
Prior art keywords
compound
methyl
formula
butyl
acid
Prior art date
Application number
BG103650A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103650A (en
Inventor
Clifford LABAW
Joseph FLISAK
Li Liu
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG103650A publication Critical patent/BG103650A/xx
Publication of BG63804B1 publication Critical patent/BG63804B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
BG103650A 1997-02-14 1999-08-10 Метод за получаване на епросартан BG63804B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3819597P 1997-02-14 1997-02-14
PCT/US1998/002412 WO1998035963A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (2)

Publication Number Publication Date
BG103650A BG103650A (en) 2000-06-30
BG63804B1 true BG63804B1 (bg) 2003-01-31

Family

ID=21898583

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103650A BG63804B1 (bg) 1997-02-14 1999-08-10 Метод за получаване на епросартан

Country Status (41)

Country Link
US (1) US6172237B1 (tr)
EP (1) EP0970073B1 (tr)
JP (1) JP4537499B2 (tr)
KR (1) KR100573638B1 (tr)
CN (1) CN1085208C (tr)
AP (1) AP1128A (tr)
AR (1) AR011125A1 (tr)
AT (1) ATE280765T1 (tr)
AU (1) AU730383B2 (tr)
BG (1) BG63804B1 (tr)
BR (1) BR9808664A (tr)
CA (1) CA2281708C (tr)
CO (1) CO4950550A1 (tr)
CY (1) CY2555B1 (tr)
CZ (1) CZ296349B6 (tr)
DE (1) DE69827240T2 (tr)
DK (1) DK0970073T3 (tr)
EA (1) EA001659B1 (tr)
EG (1) EG23935A (tr)
ES (1) ES2231963T3 (tr)
HU (1) HU228781B1 (tr)
ID (1) ID23181A (tr)
IL (1) IL131309A (tr)
IN (2) IN187999B (tr)
MA (1) MA24470A1 (tr)
MY (1) MY118704A (tr)
NO (1) NO317194B1 (tr)
NZ (1) NZ337180A (tr)
OA (1) OA11146A (tr)
PE (1) PE59299A1 (tr)
PL (1) PL192838B1 (tr)
PT (1) PT970073E (tr)
RO (1) RO119719B1 (tr)
SA (1) SA98190082B1 (tr)
SI (1) SI0970073T1 (tr)
SK (1) SK285036B6 (tr)
TR (1) TR199901936T2 (tr)
TW (1) TW399050B (tr)
UA (1) UA54487C2 (tr)
WO (1) WO1998035963A1 (tr)
ZA (1) ZA981207B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137613A1 (en) * 2006-12-27 2010-06-03 Hetero Drugs Limited Process for eprosartan
EP2181109A4 (en) * 2007-07-25 2011-08-03 Hetero Drugs Ltd CRYSTALLINE PARTICLES OF EPROSARTAN MESYLATE AND PROCESS FOR PREPARING PURE EPROSARTAN
EP2295431A3 (en) * 2007-07-25 2011-08-03 Hetero Drugs Limited Substantially pure eprosartan free base
WO2009084028A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
US20110054186A1 (en) * 2008-03-31 2011-03-03 Hetero Research Foundation Process for eprosartan intermediate
WO2010023688A2 (en) * 2008-08-25 2010-03-04 Matrix Laboratories Limited An improved process for the preparation of eprosartan
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
WO2011051975A1 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
AU9137791A (en) * 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0850225B1 (en) * 1994-05-20 2003-08-13 Smithkline Beecham Corporation Intermediate for preparing a pharmaceutically active compound

Also Published As

Publication number Publication date
SI0970073T1 (en) 2005-02-28
ATE280765T1 (de) 2004-11-15
DE69827240D1 (de) 2004-12-02
BR9808664A (pt) 2000-07-11
PL192838B1 (pl) 2006-12-29
JP4537499B2 (ja) 2010-09-01
CN1085208C (zh) 2002-05-22
AU730383B2 (en) 2001-03-08
CZ285299A3 (cs) 2000-02-16
AP9901620A0 (en) 1999-09-30
CY2555B1 (en) 2008-07-02
IN192743B (tr) 2004-05-15
JP2001510466A (ja) 2001-07-31
EA199900740A1 (ru) 2000-02-28
NZ337180A (en) 2000-11-24
CA2281708C (en) 2007-08-14
ZA981207B (en) 1998-11-12
HUP0001994A2 (hu) 2001-06-28
PE59299A1 (es) 1999-09-09
HUP0001994A3 (en) 2001-07-30
HU228781B1 (en) 2013-05-28
EP0970073A4 (en) 2001-01-24
NO993913D0 (no) 1999-08-13
TR199901936T2 (tr) 2000-04-21
NO317194B1 (no) 2004-09-13
ES2231963T3 (es) 2005-05-16
DE69827240T2 (de) 2005-10-13
OA11146A (en) 2003-04-16
IL131309A0 (en) 2001-01-28
WO1998035963A1 (en) 1998-08-20
IL131309A (en) 2002-09-12
SK285036B6 (sk) 2006-05-04
MY118704A (en) 2005-01-31
EP0970073A1 (en) 2000-01-12
EG23935A (en) 2008-01-14
ID23181A (id) 2000-03-23
PT970073E (pt) 2005-02-28
UA54487C2 (uk) 2003-03-17
CO4950550A1 (es) 2000-09-01
SK108799A3 (en) 2000-05-16
CN1247539A (zh) 2000-03-15
DK0970073T3 (da) 2005-02-21
AR011125A1 (es) 2000-08-02
MA24470A1 (fr) 1998-10-01
PL335075A1 (en) 2000-04-10
BG103650A (en) 2000-06-30
US6172237B1 (en) 2001-01-09
IN187999B (tr) 2002-08-03
EA001659B1 (ru) 2001-06-25
AU6150898A (en) 1998-09-08
AP1128A (en) 2002-12-06
NO993913L (no) 1999-08-13
KR100573638B1 (ko) 2006-04-26
TW399050B (en) 2000-07-21
CZ296349B6 (cs) 2006-02-15
RO119719B1 (ro) 2005-02-28
CA2281708A1 (en) 1998-08-20
KR20000071007A (ko) 2000-11-25
EP0970073B1 (en) 2004-10-27
SA98190082B1 (ar) 2006-08-20

Similar Documents

Publication Publication Date Title
BG63804B1 (bg) Метод за получаване на епросартан
KR102018929B1 (ko) (5-플루오로-2-메틸-3-퀴놀린-2-일메틸-인돌-1-일)-아세트산에스테르의 제조 방법
CN108383744B (zh) 一种2,6-二甲基-酪氨酸的制备方法
OA11086A (en) Process for preparing eprosartan
CN110143945B (zh) 一种4-取代基甲基-1-(2h)酞嗪酮的简便制备方法
CN110204494B (zh) 氧取代苯基咪唑类xor/urat1双重抑制剂及制备与应用
MXPA99007533A (en) Process for preparing eprosartan
JPH05505187A (ja) １―ヒドロキシアルキル―５―ニトロイミダゾール類の製造方法
JP2001064265A (ja) アルキルヒダントイン類